Giuseppe Citerio1,2, Marcelo Cypel3, Geoff J Dobb4,5, Beatriz Dominguez-Gil6, Jennifer A Frontera7, David M Greer8, Alex R Manara9, Sam D Shemie10, Martin Smith11,12, Franco Valenza13, Eelco F M Wijdicks14. 1. School of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy. giuseppe.citerio@unimib.it. 2. Neurointensive Care, Department of Emergency and Intensive Care, San Gerardo Hospital, Monza, Italy. giuseppe.citerio@unimib.it. 3. Division of Thoracic Surgery, University of Toronto, Toronto, ON, M5G 2C4, Canada. 4. Intensive Care Unit, Royal Perth Hospital, Perth, WA, Australia. 5. School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia. 6. Organización Nacional de Trasplantes, C/Sinesio Delgado 6, Pabellón 3, 28029, Madrid, Spain. 7. Cerebrovascular Center of the Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. 8. Department of Neurology, Yale University School of Medicine, New Haven, CT, USA. 9. The Intensive Care Unit, Southmead Hospital, North Bristol NHS Trust, Bristol, BS10 5NB, UK. 10. Division of Critical Care, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada. 11. Department of Neurocritical Care, National Hospital for Neurology and Neurosurgery, University College London Hospitals, London, UK. 12. National Institute for Health Research UCLH Biomedical Research Centre, London, UK. 13. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy. 14. Division of Critical Care Neurology, Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Abstract
PURPOSE: The shortage of organs for transplantation is an important medical and societal problem because transplantation is often the best therapeutic option for end-stage organ failure. METHODS: We review the potential deceased organ donation pathways in adult ICU practice, i.e. donation after brain death (DBD) and controlled donation after circulatory death (cDCD), which follows the planned withdrawal of life-sustaining treatments (WLST) and subsequent confirmation of death using cardiorespiratory criteria. RESULTS: Strategies in the ICU to increase the number of organs available for transplantation are discussed. These include timely identification of the potential organ donor, optimization of the brain-dead donor by aggressive management of the physiological consequence of brain death, implementation of cDCD protocols, and the potential for ex vivo perfusion techniques. CONCLUSIONS: Organ donation should be offered as a routine component of the end-of-life care plan of every patient dying in the ICU where appropriate, and intensivists are the key professional in this process.
PURPOSE: The shortage of organs for transplantation is an important medical and societal problem because transplantation is often the best therapeutic option for end-stage organ failure. METHODS: We review the potential deceased organ donation pathways in adult ICU practice, i.e. donation after brain death (DBD) and controlled donation after circulatory death (cDCD), which follows the planned withdrawal of life-sustaining treatments (WLST) and subsequent confirmation of death using cardiorespiratory criteria. RESULTS: Strategies in the ICU to increase the number of organs available for transplantation are discussed. These include timely identification of the potential organ donor, optimization of the brain-dead donor by aggressive management of the physiological consequence of brain death, implementation of cDCD protocols, and the potential for ex vivo perfusion techniques. CONCLUSIONS: Organ donation should be offered as a routine component of the end-of-life care plan of every patient dying in the ICU where appropriate, and intensivists are the key professional in this process.
Entities:
Keywords:
Brain death; Donation after brain death; Donation after circulatory death; Intensive care; Organ donation
Authors: Peter S Macdonald; Anders Aneman; Deepak Bhonagiri; Daryl Jones; Gerry O'Callaghan; William Silvester; Alasdair Watson; Geoffrey Dobb Journal: Crit Care Med Date: 2012-05 Impact factor: 7.598
Authors: Marcelo Cypel; Jonathan C Yeung; Mingyao Liu; Masaki Anraku; Fengshi Chen; Wojtek Karolak; Masaaki Sato; Jane Laratta; Sassan Azad; Mindy Madonik; Chung-Wai Chow; Cecilia Chaparro; Michael Hutcheon; Lianne G Singer; Arthur S Slutsky; Kazuhiro Yasufuku; Marc de Perrot; Andrew F Pierre; Thomas K Waddell; Shaf Keshavjee Journal: N Engl J Med Date: 2011-04-14 Impact factor: 91.245
Authors: Giuseppe Citerio; Ilaria Alice Crippa; Alfio Bronco; Alessia Vargiolu; Martin Smith Journal: Neurocrit Care Date: 2014-12 Impact factor: 3.210
Authors: Sarah Wahlster; Eelco F M Wijdicks; Pratik V Patel; David M Greer; J Claude Hemphill; Marco Carone; Farrah J Mateen Journal: Neurology Date: 2015-04-08 Impact factor: 9.910
Authors: Oliver K Jawitz; Vignesh Raman; Yaron Barac; Michael S Mulvihill; Carrie Moore; Ashley Y Choi; Matthew Hartwig; Jacob Klapper Journal: Ann Thorac Surg Date: 2019-07-02 Impact factor: 4.330
Authors: Geert Meyfroidt; Jan Gunst; Ignacio Martin-Loeches; Martin Smith; Chiara Robba; Fabio Silvio Taccone; Giuseppe Citerio Journal: Intensive Care Med Date: 2019-02-11 Impact factor: 17.440
Authors: Pedro Augusto Reck Dos Santos; Paulo José Zimermann Teixeira; Daniel Messias de Moraes Neto; Marcelo Cypel Journal: J Bras Pneumol Date: 2022-04-20 Impact factor: 2.800
Authors: Andre Gorgen; Hala Muaddi; Wei Zhang; Ian McGilvray; Steven Gallinger; Gonzalo Sapisochin Journal: Can J Gastroenterol Hepatol Date: 2018-01-10
Authors: Janet E Squires; Nicole Graham; Mary Coughlin; Michaël Chassé; Stefanie Linklater; Megan Greenough; Jeremy M Grimshaw; Sam D Shemie; Sonny Dhanani; Gregory A Knoll Journal: Transplant Direct Date: 2018-06-27